Xifaxan Tablet
NDC Package 55154-6777-8

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Xifaxan (rifaximin) tablets is a medication used to treat diarrhea caused by the common bacteria known as E. This formulation utilizes a tablet delivery system. Marketed by Cardinal Health 107, Llc, this product is identified by NDC 55154-6777 and is authorized under FDA application NDA021361.

Identification & Billing

NDC Package Code
55154-6777-8
Package Description
360 TABLET in 1 BOTTLE, PLASTIC
Product Code
55154-6777
11-Digit Billing Format
55154677708
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
360 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Xifaxan
Non-Proprietary Name
Rifaximin
Substance Name
Rifaximin
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
RIFAXIMIN 550 mg/1
Pharmacologic Class
Usage Information
This medication is used to treat diarrhea caused by the common bacteria known as E. coli ("traveler's diarrhea"). Rifaximin should not be used if you have a fever or bloody diarrhea. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Rifaximin is also used to treat irritable bowel syndrome with diarrhea. It is also used to prevent a brain problem caused by liver disease (hepatic encephalopathy). It may help you think more clearly.

Regulatory & Marketing

Labeler Name
Cardinal Health 107, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA021361
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-01-2010
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55154-6777-8 identifies a specific commercial package of 360 tablet in 1 bottle, plastic of Xifaxan, a human prescription drug labeled by Cardinal Health 107, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 360 billable units per package. This tablet is formulated for oral use and contains rifaximin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cardinal Health 107, Llc on May 01, 2010. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat diarrhea caused by the common bacteria known as E. coli ("traveler's diarrhea"). Rifaximin should not be used if you have a fever or bloody diarrhea. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Rifaximin is also used to treat irritable bowel syndrome with diarrhea. It is also used to prevent a brain problem caused by liver disease (hepatic encephalopathy). It may help you think more clearly.

How is this Cardinal Health 107, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154677708. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 360 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55154-6777-8
11-Digit CMS (5-4-2)
55154-6777-08

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.